Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-16-115567
Filing Date
2016-04-29
Accepted
2016-04-29 07:00:16
Documents
3
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a16-9302_110ka.htm 10-K/A 579582
2 EX-31.3 a16-9302_1ex31d3.htm EX-31.3 4635
3 EX-31.4 a16-9302_1ex31d4.htm EX-31.4 5051
  Complete submission text file 0001104659-16-115567.txt   590563
Mailing Address 699 BOYLSTON ST 8TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 8TH FLOOR BOSTON MA 02116 (617) 600-3497
EPIRUS Biopharmaceuticals, Inc. (Filer) CIK: 0001135906 (see all company filings)

EIN.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51171 | Film No.: 161602428
SIC: 2834 Pharmaceutical Preparations